Research involving lung cancer genotyping for other mutations, such as rearrangements in ALK, ROS1, or RET genes, amplifications in the MET gene, or mutations in the BRAF or HER2 genes, has started to slowly develop. The gene discussed is ALK; the disease is lung carcinoma.